GlassScriptPhysician profile
Usman A Siddiqui
NPI 1114927712
$11,341.18
in general payments reported to CMS, 2019-2025
22 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $34.07 · 2021: $938 · 2022: $367 · 2023: $8,758 · 2024: $525 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,366 · Travel and Lodging: $2,207 · Food and Beverage: $824 · Education: $28.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,365.63 |
| Travel and Lodging | $2,206.86 |
| Food and Beverage | $824.36 |
| Education | $28.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,672.24 | 2023-2024 | Amplatzer Amulet |
| Biogen, INC. | $400.90 | 2021-2023 | Vumerity, Tysabri |
| Abbvie INC. | $315.66 | 2021 | |
| Acadia Pharmaceuticals INC | $297.04 | 2023 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $235.93 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $204.16 | 2019-2020 | |
| Amgen INC. | $199.63 | 2019 | |
| Greenwich Biosciences, INC. | $142.44 | 2021 | |
| Horizon Therapeutics Plc | $124.25 | 2022 | |
| Sk Life Science, INC. | $122.29 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $120.19 | 2021 | |
| Idorsia Pharmaceuticals US INC | $89.32 | 2023 | Quviviq |
| Bard Peripheral Vascular, INC. | $83.95 | 2019 | |
| Reflow Medical INC | $75.00 | 2025 | |
| Akcea Therapeutics, INC. | $71.88 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $66.70 | 2025 | General - Therapies |
| Sumitomo Pharma America, INC. | $49.89 | 2023 | Aptiom |
| Ge Healthcare | $22.77 | 2019 | |
| Allergan, INC. | $15.07 | 2020 | |
| Medtronic, INC. | $13.91 | 2022 | |
| Emd Serono, INC. | $13.17 | 2019 | |
| Neuronetics, INC. | $4.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Siddiqui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.